Ischemic modulation of cardiac autonomic innervation  by Zipes, Douglas P.
1424 
Editorial Comment 
Ischemic Modulation of Cardiac 
Autonomic Innervation* 
DOUGLAS P. ZIPES, MD, FACC 
Indianapolis, Indiana 
Numerous studies in experimental animals have established 
the importance of the autonomic nervous system in the 
genesis of a wide variety of cardiac arrhythmias. The most 
compelling clinical data supporting the role of sympathetic 
innervation in ischemia-related arrhythmias come from the 
studies demonstrating a reduction in total and sudden car-
diac death in patients treated with a beta-adrenoceptor 
antagonist after myocardial infarction. How beta-adrenocep-
tor blockers reduce the death rate is not yet clear. 
The present study. The article by Dae et al. (1) takes us 
one step closer to understanding mechanisms of sympathet-
ically mediated arrhythmias by employing a technique to 
study cardiac sympathetic innervation. Metaiodobenzyl-
guanidine (MIBG), a guanethidine analogue developed at the 
University of Michigan and used initially to identify adrenal 
tissue in patients with pheochromocytoma (2), can be em-
ployed to image cardiac sympathetic nerves and detect 
whether sympathetic terminals are present and take up 
MIBG normally (3,4). A defect in the MIBG cardiac scinti-
gram in an area that simultaneously shows a normal thal-
lium-201 image outlines viable myocardium with normal 
blood flow and normal cellular function, at least for thallium-
201 uptake, but absent or diminished MIBG uptake. The 
latter is due to reduced or absent cardiac sympathetic nerve 
terminals, that is, postganglionic cardiac sympathetic dener-
vation. 
Effects of ischemia and infarction on cardiac autonomic 
innervation. These effects have been studied for some years 
and provide the underpinnings for our knowledge of the 
MIBG response (5). Knowing the intracardiac routes of 
autonomic neural innervation allows one to predict the 
different effects produced by a subendocardial versus a 
transmural lesion. Afferent and efferent vagal fibers in the 
dog cross the atrioventricular (A V) groove in the superficial 
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subepicardium and then enter the myocardium where they 
are located in the subendocardium, penetrating upward to 
innervate the epicardium. They can be interrupted by an 
epicardial lesion (epicardial phenol application, surgical dis-
section at the A V groove) or by an endocardial lesion 
(subendocardial ischemia or infarction) within the ventricle. 
In contrast, sympathetic afferent and efferent fibers are 
located in the superficial subepicardium throughout their 
course, primarily in the periadventitia of the coronary arter-
ies, diving intramurally to innervate the endocardium. They 
can be interrupted by epicardial lesions at the A V groove 
and within the ventricle. Therefore, transmural myocardial 
ischemia or infarction that involves the sub epicardium will 
interrupt "downstream" efferent sympathetic innervation. 
In contrast, subendocardial ischemia or infarction spares the 
subepicardium and sympathetic nerves, but interrupts the 
vagus. Although sympathetic responsiveness in the surviv-
ing subepicardial shell overlying a subendocardial infarction 
is reduced to some degree (6), intact sympathetic innervation 
with vagal denervation can create a heart prone to develop-
ing arrhythmias (7). The present study ofDae et al. (1) using 
MIBG scintigraphy confirms some of the different efferent 
sympathetic denervation patterns produced by nontransmu-
ral and transmural infarction. 
It is important to stress that ischemic-neural interaction is 
dynamic and changing. One MIBG thallium-201 scan creates 
a static, snapshot view of potentially evolving pathophysiol-
ogy (5). For example, acute myocardial ischemia initially 
causes functional neural denervation, probably related to 
accumulation of ischemic catabolites in the myocardium in 
which the nerve axons lie. Resumption of coronary flow 
restores these early. reversible neural responses. More 
permanent denervation takes hours of ischemia to establish. 
But even after anatomic disruption of nerve axons with more 
permanent denervation has occurred, a new phenomenon is 
observed, that of denervation supersensitivity. Denervation 
supersensitivity creates an area of myocardium that re-
sponds in an exaggerated fashion to catecholamines. Such a 
response appears to generate an arrhythmogenic state that is 
eliminated by beta-adrenoceptor blockers (5) and may also 
provide a substrate for heterogeneous drug actions on the 
heart and a possible cause of proarrhythmia (8). Finally, 
after 12 to 14 weeks, reinnervation occurs and the MIBG 
defect normalizes. Interestingly, and as yet unexplained, 
supersensitivity persists despite reinnervation (5). Some of 
these sympathetic patterns have been documented in pa-
tients with coronary artery and other forms of heart disease 
(4). 
Clinical implications. The clinical importance in the 
pathogenesis of ventricular arrhythmias, especially sudden 
cardiac death, of the regional sympathetic denervation pat-
terns shown in the canine studies described and in the MIBG 
scintigrams in humans (4) has not yet been established. It 
should be a priority for future research. Such a link, if 
forged, will provide insight into sympathetically responsible 
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mechanisms causing sudden cardiac death and may permit 
development of more specifically directed antiarrhythmic 
therapy (9). For example, speeding the process of reinner-
vation or preventing the initial denervation may prove to 
have an antiarrhythmic effect. If the connection between 
regional sympathetic denervation and arrhythmias cannot be 
established, then cardiac MIBG scintigraphy will be an 
interesting but perhaps not clinically useful tool. I am betting 
on the former possibility and anticipate that studies like 
those by Dae et al. (1) will yield important insights into these 
mechanisms. 
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